| Literature DB >> 29158864 |
Serge Muleka Ngoie1, Philippe Mulenga2, Olivier Mukuku1, Christian Ngama Kakisingi1, Cédrick Milindi Sangwa3, Pascal Tshimwang Nawej4, Claude Mulumba Mwamba1, Dophra Nkulu Ngoy1, Faustin Wa Pa Manda Muteta1.
Abstract
INTRODUCTION: Chronic kidney disease is fast becoming a worldwide public health problem due to the increase of hypertension and diabetes mellitus, its main risk factors. In countries like DRC where majority of population are in the low income bracket, very few studies about this disease, usually diagnosed at a very advanced stage have been conducted. As a result of such, cases are not always properly taken care of and managed.Entities:
Keywords: Chronic kidney disease; Lubumbashi; biology; clinical; factors
Mesh:
Substances:
Year: 2017 PMID: 29158864 PMCID: PMC5687869 DOI: 10.11604/pamj.2017.28.41.9810
Source DB: PubMed Journal: Pan Afr Med J
Classification de la maladie rénale chronique
| Stade | DFG (ml/min/1,73m2) | Description |
|---|---|---|
|
| ≥ 90 | Maladie sans I Rénale |
|
| 60-89 | I Rénale Chronique légère |
|
| 45-59 | I R chronique moyennement modérée |
|
| 30-44 | I R chronique moyennement modérée |
|
| 15-29 | I R chronique sévère |
|
| < 15 | I R chronique Terminale |
Paramètres socio démographiques
| Caractéristique | Effectif | Pourcentage |
|---|---|---|
|
| ||
| >30 ans | 5 | 8,34% |
| 30-39 ans | 6 | 10,01% |
| 40-49 ans | 12 | 20,00% |
| 50-59 ans | 22 | 36,68% |
| 60-69 ans | 11 | 18,33% |
| ≥70 ans | 4 | 6,67% |
|
| ||
| Féminin | 26 | 43 ,33% |
| Masculin | 34 | 56,67% |
|
| ||
| Primaire | 2 | 3,33% |
| Secondaire | 31 | 51,67% |
| Supérieur | 27 | 45,00% |
Répartition des patients selon les facteurs associés
| Facteurs associés | Féminin (n=26) | Masculin (=34) | Total | P |
|---|---|---|---|---|
| Age≥60 ans | 6(23,08%) | 9(26,47%) | 15(25%) | 1,000 |
| Histoire familiale d’HTA | 11(42,31%) | 17(50%) | 28(46,67%) | 0,7408 |
| Histoire familiale de diabète sucré | 4(15,38%) | 11(32,35%) | 15(25%) | 0,2233 |
| HTA | 17(65,38%) | 23(67,65%) | 40(66,67%) | 0,9266 |
| Diabète sucré | 6(23,08%) | 9(26,47%) | 15(25%) | 1,000 |
| Histoire personnelle de maladie rénale | 3(11,54%) | 7(20,59%) | 10(16,67%) | 0,4905 |
| Prise d’alcool | 4(15,38%) | 22(64,71%) | 26(43,33%) | 0,0001 |
| Prise de tabac | 0(0%) | 9(26,47%) | 9(15%) | 0,0037 |
| Usage des AINS | 8(30,77%) | 14(41,18%) | 22(36,67%) | 0,5764 |
| Usage de produits traditionnels | 7(26,92%) | 14(41,18%) | 21(35%) | 0,3821 |
| Absence d’activité physique | 24(92,31%) | 19(55,88%) | 43(71,67%) | 0,0031 |
| Notion de dyslipidémie | 2(7,69%) | 3(8,82%) | 5(8,33%) | 1,000 |
| Histoire de maladies cardiaques | 5(19,23%) | 9(26,47%) | 14(23,33%) | 0,5550 |
| Goutte | 0(0%) | 2(5,88%) | 2(3,33%) | 0,5005 |
| HIV | 3(11,54%) | 4(11,76%) | 7(11,67%) | 1,000 |
| Drépanocytose | 1(3,85%) | 1(2,94%) | 2(3,33%) | 1,000 |
| Maladies systémiques | 1(3,85%) | 2(5,88%) | 3(5,0%) | 1,000 |
| Infections urinaires à répétition | 1(3,85%) | 5(14,71%) | 6(10,00%) | 0,2206 |
Figure 1Répartition selon les paramètres cliniques
Répartition selon les paramètres cliniques
| Paramètres cliniques | Féminin | Masculin | Total | P |
|---|---|---|---|---|
| IMC moyen | 24,51 ± 7,55 | 22,28 ± 3,11 | 23,25 ± 5,55 | 0,1245 |
| Obésité | 5 (19, 23%) | 1 (2, 94%) | 6 (10, 00%) | 0,0492 |
| Systole moyenne | 158,38 ± 37,62 | 160,94 ±36,51 | 159,83 ±36,70 | 0,7918 |
| Diastole moyenne | 95,50 ± 22,49 | 93,97 ± 22,52 | 94,63 ± 22,33 | 0,7952 |
| T.A élévée | 17 (65, 38%) | 23 (67, 65%) | 40 (66, 67%) | 0,9266 |
| Glycémie | 4 (15, 38%) | 4 (11, 76 %) | 8 (13, 33%) | 0,7172 |
| Glycémiemoyenne | 112,84±50,51 | 109,38 ±53,09 | 110,88 ±53,09 | 0,8046 |
| Syndrome métabolique | 2 (7, 69%) | 3 (8, 82%) | 5 (8, 33%) | 1,0000 |
Répartition des paramètres biologiques selon les stades de la maladie
| Variable | Stade <5(n=21) | Stade 5(n=39) | Total(n=60) | P |
|---|---|---|---|---|
|
| ||||
| Moyenne (±ET) | 6,76 ± 2,37 | 6,90 ± 2,17 | 6,85 ± 2,22 | 0,8250 |
| Hyperuricémie n (%) | 12 (57, 14%) | 17 (43, 59%) | 0,4183 | |
| Hémoglobine | ||||
| Moyenne (±ET) | 9,98 ± 2,15 | 8,26 ± 2,18 | 8,86 ±2,31 | 0,0047 |
| Anémie n (%) | 17 (80, 95%) | 36 (92, 31%) | 0,2262 | |
|
| ||||
| Moyenne (±ET) | 8,54 ± 1,04 | 8,80 ± 1,64 | 8,71 ± 1,45 | 0,5211 |
| Hypocalcémie n (%) | 11 (52, 38%) | 19 (48, 72%) | 1,0000 | |
|
| ||||
| Moyenne (±ET) | 4,54 ± 1,12 | 4,71 ± 1,13 | 4,65 ± 1,12 | 0,5729 |
| Hyperkaliémie n (%) | 4 (19, 05%) | 8 (20, 51%) | 1,0000 |